NCT07590726
PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors
Not Yet Recruiting · Not Applicable · Rigshospitalet, Denmark · registry updated 2026-05-19
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
Serious brain diseases and injuries affect not only the person who becomes ill or injured, but also their family. Relatives of people with acquired brain injury (ABI) or malignant brain tumor (MBT) often take on a major role in daily care, decision-making, and coordination across healthcare services. This role can include managing information, supporting rehabilitation, and acting as a link between hospital care and community rehabilitation. Many relatives report high levels of stress, uncertainty, and emotional burden, especially during transitions between care settings. Despite recommendations for greater involvement of relatives, support for this group is often uneven and poorly coordinated across healthcare sectors. Relatives frequently experience lack of overview, limited guidance, and unclear expectations regarding their role. These challenges may increase caregiver burden and negatively affect both relatives' well-being and the continuity of care. The PIRe 2.0 study aims to further test, and implement a structured intervention to support systematic involvement of relatives of people with ABI or MBT across hospital and community rehabilitation services....
Inclusion
- Primary relative of an adult diagnosed with acquired brain injury (ABI) or malignant brain tumor (MBT), admitted to a participating hospital department.
- Formally identified as the primary relative by the patient.
- Aged ≥18 years.
- Ability to read, understand, and complete questionnaires in Danish.
Exclusion
- Insufficient proficiency in Danish to complete questionnaires and participate in structured conversations.
- Concurrent participation in another interventional study with a similar aim that may interfere with the present study.